MedTrace Logo

Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)

NCT02059343 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2014-11-24

No results posted yet for this study

Summary

Dexmedetomidine is increasingly used for sedation in children placed on cardiopulmonary bypass for heart surgery. It is also often used after surgery and may be particularly helpful for children with heart disease. In order for this medication to be helpful and to minimize risks associated with taking the medication, it is important to provide correct dosing for this medication. Based on evidence from studies of other medications used during heart surgery, it is likely that dosing of dexmedetomidine while on cardiopulmonary bypass is different from dosing in other settings. The purpose of this study is to evaluate how the heart-lung bypass machine affects dexmedetomidine levels in the body.

Conditions

  • Pharmacokinetics
  • Cardiopulmonary Bypass
  • Children

Sponsors & Collaborators

Principal Investigators

  • Kevin Watt, MD · Duke University

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-10-31
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02059343 on ClinicalTrials.gov